Real-time PCR (qPCR) & Digital PCR (dPCR) Market Demand, Status, Analysis And Forecasts To 2026| Grand View Research, Inc
“The global Real-time PCR (qPCR) and Digital PCR (dPCR) market size was valued at USD 2.25 billion in 2018. It is expected to expand at a CAGR of 8.5% during the forecast period.”
The global real-time pcr and digital pcr market size is anticipated to reach USD 4.33 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.5% during the forecast period. Growing demand for Rapid Diagnostics Tests (RTDs) is one of the high impact rendering drivers for this market. The demand for RDTs is likely to witness strong growth as local governments across the globe seek to incorporate these tests to improve the diagnosis and treatment of infectious diseases. The emergence of RDTs as an important tool in the management of infectious diseases owing to the ability to provide rapid results in remote areas with limited healthcare infrastructure is likely to fuel the growth of the Polymerase Chain Reaction (PCR) systems which are used extensively to conduct these diagnostic procedures. In addition, high prevalence of infectious diseases is one of the major factors contributing to the market growth. According to the estimates by the World Health Organization (WHO), lower respiratory infections, diarrheal diseases, and tuberculosis were ranked among the top ten causes of deaths worldwide in 2016. New cases of other infectious diseases, such as HIV/AIDS and malaria among others continue to witness sharp increase in developing countries which is expected to substantially increase the patient population, driving the need for better diagnosis options. Furthermore, inorganic growth strategies such as mergers and acquisitions employed by major PCR manufacturers to broaden their product portfolio and to develop novel qPCR and dPCR products is another factor expected to propel the market during the forecast period. For instance, in January 2017, RainDance Technologies, Inc. was acquired by Bio-Rad Laboratories, Inc. which is expected to strengthen the company’s position in the field of droplet digital PCR and next generation sequencing.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/real-time-pcr-qpcr-digital-pcr-dpcrmarket
Follow Us: